Organization-level Youth Engagement Approach for Substance Misuse Prevention

October 17, 2025 updated by: Wake Forest University Health Sciences
This study will consist of a small pilot Randomized Controlled Trial (RCT). Four prevention organizations will be randomized either to include Youth Engagement in prevention efforts (treatment) or not (control). The study team will attempt to match the treatment and control groups on relevant characteristics such as geographic location (e.g., urban, rural), population served (e.g., church-based, school-based), and/or prior Youth Engagement involvement. The objective of this study is to evaluate the preliminary effectiveness of YE as a prevention strategy for opioid misuse in a small pilot randomized control trial (RCT). This pilot study will examine the effects of the YE prevention strategy on (a) organization-level outcomes, such as perceived value added to prevention programming and (b) individual-level outcomes such as personal skills and attitudes as well as knowledge and attitudes about substances including opioids. Up to 15 leaders/staff and 45 youth/young adults (60 people overall) will be recruited for the study.

Study Overview

Detailed Description

Substance misuse is a major public health problem and opioid misuse is an acute problem in rural and high poverty communities. Adolescence and young adulthood is a formative time for positive social development, as young people increase their needs for maturity and autonomy, define their identities, and carve out their roles in society. But many youth and young adults are isolated within communities, feel that they do not matter, and lack meaningful opportunities to engage with society and form positive connections with prosocial institutions. Further, community systems and settings that serve youth and young adults often do not effectively involve them. Engaging youth and young adults in their communities and in the prevention systems targeting substance misuse may prevent the use of substances by targeting two pathways. The first is an individual pathway via bolstering psychosocial development and reducing risks for opioids by providing youth and young adults with meaningful prosocial opportunities to fulfill developmental needs. The second is an environmental pathway via affecting health system and community-based settings through improving prevention efforts targeting young adults. This project tests an organization-level Youth Engagement (YE) approach to improve prevention.

Only organizations randomized to treatment will include youth/Young Adult (YA) participants. Youth/YA survey data will be collected at the start of their participation in the YE strategy (pre-YE) and 6 months later (post-YE). At the post-YE the study team will interview a subset of interested YE group participants to qualitatively assess their experiences and to identify, in their own voices, what aspects of YE emerge as important to youth development and their health-related decision-making.

The timeframe for this phase will be 12-18 months.

Study Type

Interventional

Enrollment (Actual)

43

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Winston-Salem, North Carolina, United States, 27157
        • Wake Forest School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

INCLUSION CRITERIA:

Organizational leaders/staff:

  • Leaders or staff of community-based prevention organizations based in North Carolina
  • Organizations are youth/young adult-serving and focused on opioid misuse prevention
  • Organizations demonstrate readiness, interest, need, and resources to invest in Youth Engagement as part of prevention
  • Leaders or staff are or would be involved in implementing Youth Engagement strategy at the organization
  • Leaders or staff are able to speak and read English fluently

Youth/young adult participants involved with organizations:

  • Adolescents and young adults age 11 - 29
  • Interested in participating in Youth Engagement with the community organization
  • Able to speak and read English fluently

EXCLUSION CRITERIA:

• Organizations already incorporating a high level of Youth Engagement in its prevention work

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
In this arm the study will implement an organization-level Youth Engagement prevention strategy by systematically incorporating Youth Engagement into prevention efforts in a community setting. Youth (individuals) participating in the intervention organizations' programming following the organization's completion of the YE intervention will complete surveys.
Systematically incorporating Youth Engagement into prevention efforts in a community setting
No Intervention: Control group
This arm will receive no intervention. Control group organizations will continue their normal prevention strategy without the inclusion of a Youth Engagement component

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Staff Surveys--Youth Engagement (YE) Prevention Programming Value
Time Frame: Month 6
This outcome will be assessed through a survey measure administered to the organization leaders and staff in the YE intervention organizations only. The survey measures will be on a 1-5 scale with a higher score meaning a higher perceived programming value.
Month 6
Perceived Retention of Youth/Young Adults in Youth Engagement (YE) Prevention Programming
Time Frame: Month 6
This outcome will be assessed through a survey measure on a 1-5 scale administered to the organization leaders and staff in the YE intervention organizations only, with higher scores indicated better retention.
Month 6
Perceived Usefulness of Youth Engagement (YE) Prevention
Time Frame: Month 6
This outcome will be assessed through a survey measure administered to the organization leaders and staff in the YE intervention organizations only. The survey items will ask about perceived usefulness of the YE intervention for youth/young adults, the organization, and the community. Items will be on a 1-5 scale with higher scores indicating higher perceived usefulness.
Month 6
Perceived Effectiveness, Quality, Reach, and Usefulness of General Prevention Approaches
Time Frame: Month 6
This outcome will be assessed through a survey measure administered to the organization leaders and staff in the Youth Engagement (YE) intervention organizations and comparison organizations. The survey measures will be on a 1-5 scale with higher scores indicating higher perceived quality, reach, and usefulness.
Month 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Youth/Young Adults: Leadership and Communication Skills
Time Frame: Baseline and Month 6
This outcome will be assessed through a survey measure administered to young adults involved in the youth engagement (YE) intervention at baseline (pre-YE) and 6 months later (post-YE). The survey measures will be on a 1-5 scale with higher scores indicating greater leadership and communication skills .
Baseline and Month 6
Youth/Young Adults: Self-efficacy
Time Frame: Baseline and Month 6
This outcome will be assessed through a survey measure administered to young adults involved in the youth engagement (YE) intervention at baseline (pre-YE) and 6 months later (post-YE). The survey measures will be on a 1-5 scale with higher scores indicating higher self-efficacy.
Baseline and Month 6
Youth/Young Adults: Self Esteem
Time Frame: Baseline and Month 6
This outcome will be assessed through a survey measure administered to young adults involved in the youth engagement (YE) intervention at baseline (pre-YE) and 6 months later (post-YE). The survey measures will be on a 1-5 scale with higher scores indicating greater self esteem.
Baseline and Month 6
Youth/Young Adults: Social Connectedness
Time Frame: Baseline and Month 6
This outcome will be assessed through a survey administered to young adults involved in the youth engagement YE intervention at baseline (pre-YE) and 6 months later (post-YE). The survey measures will be on a 1-5 scale with higher scores indicating greater social connectedness.
Baseline and Month 6
Youth/Young Adults: Meaningful Social Role
Time Frame: Baseline and Month 6
This outcome will be assessed through a survey measure administered to young adults involved in the youth engagement (YE) intervention at baseline (pre-YE) and 6 months later (post-YE). The survey measures will be on a 1-5 scale with higher scores indicating higher perceived meaningful social role.
Baseline and Month 6
Youth/Young Adults: Beliefs and Intentions Related to Substance Use
Time Frame: Baseline and Month 6
This outcome will be assessed through a survey measure administered to young adults involved in the youth engagement (YE) intervention at baseline (pre-YE) and 6 months later (post-YE). The survey measures will be on a 1-5 scale with higher scores indicating safer beliefs about perceived risks.
Baseline and Month 6

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exploratory--Youth Engagement Prevention Programming Value, Qualitative
Time Frame: Month 6
This exploratory outcome will be assessed qualitatively through interviews with organizational leaders and staff
Month 6
Exploratory--Retention of Youth/Young Adults in Youth Engagement Prevention Programming, Qualitative
Time Frame: Month 6
This exploratory outcome will be assessed qualitatively through interviews with organizational leaders and staff
Month 6
Exploratory--Reach of Youth Engagement Prevention Efforts in the Community, Qualitative
Time Frame: Month 6
This exploratory outcome will be assessed qualitatively through interviews with organizational leaders and staff
Month 6
Exploratory--Perceived Usefulness of Youth Engagement Prevention, Qualitative
Time Frame: Month 6
This exploratory outcome will be assessed qualitatively through interviews with organizational leaders and staff
Month 6
Exploratory--Perceived Effectiveness, Quality, Reach, and Usefulness of General Prevention Approaches, Qualitative
Time Frame: Month 6
This exploratory outcome will be assessed qualitatively through interviews with organizational leaders and staff
Month 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Parissa J Ballard, PhD, Wake Forest University Health Sciences

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 14, 2024

Primary Completion (Actual)

July 1, 2025

Study Completion (Actual)

July 1, 2025

Study Registration Dates

First Submitted

February 9, 2023

First Submitted That Met QC Criteria

February 9, 2023

First Posted (Actual)

February 21, 2023

Study Record Updates

Last Update Posted (Estimated)

October 31, 2025

Last Update Submitted That Met QC Criteria

October 17, 2025

Last Verified

December 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • IRB00091590
  • 5K01DA048201-03 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is not a plan to make IPD available. The information collected about organizations and from individual participants will be kept confidential; only aggregate results will be reported in manuscripts and reports.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance Use

Clinical Trials on Organization-level Youth Engagement prevention strategy

Subscribe